BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 28939389)

  • 1. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope peptides and immunotherapy.
    Tanabe S
    Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD; Valmonte GR; de Guia RM
    Protein Pept Lett; 2007; 14(10):992-1002. PubMed ID: 18220997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
    Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
    Valenta R; Campana R; Niederberger V
    Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.
    Baranyi U; Farkas AM; Hock K; Mahr B; Linhart B; Gattringer M; Focke-Tejkl M; Petersen A; Wrba F; Rülicke T; Valenta R; Wekerle T
    EBioMedicine; 2016 May; 7():230-9. PubMed ID: 27322476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
    Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
    Front Immunol; 2020; 11():1368. PubMed ID: 32733455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for peptide-based immunotherapy for dog allergy.
    Virtanen T
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Aspects of Allergens and Allergy.
    Valenta R; Karaulov A; Niederberger V; Gattinger P; van Hage M; Flicker S; Linhart B; Campana R; Focke-Tejkl M; Curin M; Eckl-Dorna J; Lupinek C; Resch-Marat Y; Vrtala S; Mittermann I; Garib V; Khaitov M; Valent P; Pickl WF
    Adv Immunol; 2018; 138():195-256. PubMed ID: 29731005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide and Recombinant Allergen Vaccines for Food Allergy.
    Cook QS; Burks AW
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):162-171. PubMed ID: 29368278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy.
    D'souza N; Weber M; Sarzsinszky E; Vrtala S; Curin M; Schaar M; Garib V; Focke-Tejkl M; Li Y; Jones R; Chen H; Valenta R; Sun B
    Front Immunol; 2021; 12():719573. PubMed ID: 34512644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and recombinant immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance and allergy.
    Hamad A; Burks W
    Semin Immunol; 2017 Apr; 30():28-35. PubMed ID: 28739336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.